You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Amgen Inc. (AMGN $325.31)
- $325.31 P/E (TTM): 24.54X Cap: $175.17B
- View AMGN Profile
- View Questions on AMGN
Regeneron Pharmaceuticals Inc. (REGN $752.62)
- $752.62 P/E (TTM): 17.73X Cap: $79.09B
- View REGN Profile
- View Questions on REGN
Vertex Pharmaceuticals Incorporated (VRTX $455.71)
- $455.71 P/E (TTM): 32.04X Cap: $115.62B
- View VRTX Profile
- View Questions on VRTX
iShares Biotechnology ETF (IBB $169.38)
- $169.38 P/E (TTM): 22.53X Cap: $8.56B
- View IBB Profile
- View Questions on IBB
Mettler-Toledo International Inc. (MTD $1,412.47)
- $1,412.47 P/E (TTM): 34.8X Cap: $28.85B
- View MTD Profile
- View Questions on MTD
Solid Biosciences Inc. (SLDB $5.71)
- $5.71 Cap: $458M
- View SLDB Profile
- View Questions on SLDB
TCR2 Therapeutics Inc. (TCRR)
- Cap: $58M
- View TCRR Profile
- View Questions on TCRR
NextCure Inc. (NXTC $11.47)
- $11.47 Cap: $60M
- View NXTC Profile
- View Questions on NXTC

Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?

Read Answer Asked by Larry M. on May 11, 2022

NextCure Inc. (NXTC $11.47)
- $11.47 Cap: $60M
- View NXTC Profile
- View Questions on NXTC

Q: Can you comment about this US drug Co. developing immuno-medicines for Cancer.

Read Answer Asked by Vinod on November 15, 2019

Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!

First Name *

Last Name *

E-mail *

Password *

I have read and agree to the Terms of Use